MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Insys Therapeutics Company Profile (NASDAQ:INSY)

Consensus Ratings for Insys Therapeutics (NASDAQ:INSY) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $55.00 (54.93% upside)

Analysts' Ratings History for Insys Therapeutics (NASDAQ:INSY)
Show:
DateFirmActionRatingPrice TargetActions
7/2/2015Piper JaffrayReiterated RatingBuy$38.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Jefferies GroupReiterated RatingBuy$63.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015OppenheimerReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015Jefferies GroupSet Price TargetBuy$63.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2015OppenheimerReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/12/2015RBC CapitalBoost Price TargetOutperform$65.00 -> $71.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2015RBC CapitalBoost Price TargetOutperform$57.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2015Jefferies GroupBoost Price TargetBuy$51.00 -> $63.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/23/2014Piper JaffrayBoost Price TargetOverweight$51.00 -> $64.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/15/2014RBC CapitalBoost Price TargetOutperform$53.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/8/2014Jefferies GroupInitiated CoverageBuy$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2014RBC CapitalBoost Price TargetOutperform$51.00 -> $53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2014OppenheimerDowngradeOutperform -> Market Perform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2014Piper JaffrayInitiated CoverageOverweight$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014RBC CapitalInitiated CoverageOutperform$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2014OppenheimerBoost Price Target$30.67 -> $58.67View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2014JMP SecuritiesBoost Price TargetOutperform$33.33 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2013JMP SecuritiesBoost Price TargetMarket Outperform$20.00 -> $33.33View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2013OppenheimerBoost Price TargetOutperform$19.33 -> $30.67View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2013JMP SecuritiesSet Price Target$12.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2013OppenheimerBoost Price TargetOutperform$15.33 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2013Wells Fargo & Co.Initiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2013OppenheimerInitiated CoverageOutperform -> Outperform$15.33View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/3/2013 forward)